Flashy lungs and sarcoidosis: not always a sign of disease activity
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024010. doi: 10.36141/svdld.v41i1.14626.ABSTRACTThis is the case of a 68-year-old man with known cardiac sarcoidosis undergoing treatment with methotrexate who presented with new onset of dyspnea and lipothymia. FDG-PET/CT revealed pathological uptake within lung parenchyma which resolved following discontinuation of methotrexate, compatible with methotrexate-induced pneumonitis. This is the first case of methotrexate-induced pneumonitis documented by FDG-PET/CT.PMID:38567563 | DOI:10.36141/svdld.v41i1.14626 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Yousif A Lucinian Patrick Martineau Francois Harel Matthieu Pelletier-Galarneau Source Type: research
Coexistent sarcoidosis mimics metastasis in a patient with early-stage non-small cell lung cancer: a case report
CONCLUSIONS: Coexistent sarcoid-like reaction may mimic metastatic lung cancer. A multidisciplinary approach and sequential diagnostic biopsies can prevent unnecessary surgery or inadequate treatment by distinguishing between coexistent sarcoidosis and metastatic lung cancer.PMID:38567562 | DOI:10.36141/svdld.v41i1.14700 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Xiang Zhao Yuan Cheng Wei Wang Source Type: research
Sarcoidosis as a cause of chronic back pain: a case report
In this report, we present a case involving a previously healthy 55-year-old woman who sought medical attention due to chronic back pain. She was subsequently diagnosed with spinal sarcoidosis, based on MRI, PET scan, and biopsy results. Furthermore, treatment with prednisolone monotherapy demonstrated substantial improvement in her symptoms.PMID:38567561 | DOI:10.36141/svdld.v41i1.14813 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Georges El Hasbani Jessica Nicolas Vicky Najjar Ali Jawad Imad Uthman Source Type: research
Incidence, management and prognosis of new-onset sarcoidosis post COVID-19 infection
CONCLUSIONS: Our result suggests there is a potential link between COVID-19 and new-onset sarcoidosis. The potential mechanism for this is through cytokine mediated immune modulation in COVID-19 infection. Obtaining a tissue sample remains key in confirming the diagnosis of sarcoidosis and this may be delayed during active COVID-19 infection.PMID:38567560 | DOI:10.36141/svdld.v41i1.15027 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Oliver Vij Mrinalini Dey Kirsty Morrison Koushan Kouranloo Source Type: research
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity
CONCLUSIONS: Our results display how CPET and spirometry data complement each other for sarcoidosis disease staging, and how these tests are able to detect disease activity. Our findings suggest that CPET, a repeatable and non-invasive functional test, should be more routinely performed and taken into account in sarcoidosis patient follow-up.PMID:38567559 | DOI:10.36141/svdld.v41i1.15125 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Chiara Torregiani Matia Reale Marco Confalonieri Franca Dore Carmelo Crisafulli Elisa Baratella Francesco Salton Paola Confalonieri Barbara Ruaro Guido Maiello Source Type: research
Scarring alopecia from cutaneous sarcoidosis of the scalp
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024018. doi: 10.36141/svdld.v41i1.15660.NO ABSTRACTPMID:38567553 | DOI:10.36141/svdld.v41i1.15660 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Michelle Sikora Chinemelum Obijiofor Kristen Lo Sicco Avrom Caplan Source Type: research
Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024024. doi: 10.36141/svdld.v41i1.15515.NO ABSTRACTPMID:38567554 | DOI:10.36141/svdld.v41i1.15515 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Laura C Price Vaileios Kouranos Robert Baughman Chloe Bloom Iain Stewart Oksana Shlobin Steven Nathan Konstantinos Dimopoulos Jonathan Falconer Rohit Gupta Colm McCabe Chinthaka Samaranayake Thomas Mason Bhashkhar Mukherjee Catherine Taube Ankita Sahni Al Source Type: research
Diagnostic yield of the Kveim test in sarcoidosis patients
CONCLUSIONS: Conventional laboratory modalities were useful for the assessment of disease activity and identification of organ involvement. Kveim test revealed a significant diagnostic yield for all stages of sarcoidosis. The lowest output was achieved in stage IV patients due to the waning of active granulomatous inflammation. The highest diagnostic sensitivity was obtained by an integrated analysis of the conventional laboratory and the Kveim test results for all aspects of sarcoidosis.PMID:38567556 | DOI:10.36141/svdld.v41i1.15253 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Cuneyt Tetikkurt Emre Yanardag Muammer Bilir Halil Yanardag Ugur Kimyon Source Type: research
Prognostic significance of antifibrotic agents in idiopathic pulmonary fibrosis after initiation of long-term oxygen therapy
CONCLUSION: In IPF patients who were introduced LTOT, treatment with antifibrotic agents was the independent factor for favorable survival. Treatment with antifibrotic agents may improve prognosis of IPF even after initiation of LTOT.PMID:38567555 | DOI:10.36141/svdld.v41i1.15264 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Mayuko Ishiwari Yuta Kono Yuki Togashi Kenichi Kobayashi Ryota Kikuchi Mariko Kogami Shinji Abe Source Type: research
Cross-cultural adaptation and validation of Leicester Cough Questionnaire in sarcoidosis: the persian version
CONCLUSIONS: The psychometric properties showed that the Persian version of LCQ is a valid and reliable measure to evaluate cough-specific quality of life and is a fit-for-purpose measure for use in patients with pulmonary sarcoidosis and the results can guide clinicians in treatment decisions.PMID:38567558 | DOI:10.36141/svdld.v41i1.15203 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Mohammad Rahdar Arda Kiani Sima Noorali Arezoo Bakhshandeh Fatemeh Sadat Hosseini-Baharanchi Shadi Shafaghi Atefeh Abedini Amir Behnam Kharazmi Source Type: research
Risk of depression and anxiety in 7.302 patients with sarcoidosis: a nationwide cohort study
CONCLUSIONS: Sarcoidosis cases had a higher risk of A/D compared with matched comparators during 18 years of follow-up. The risk of developing A/D was greater for male and female cases and within all age-groups compared with the matched comparators.PMID:38567557 | DOI:10.36141/svdld.v41i1.15213 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Melina Gade Sikj ær Ole Hilberg Ingeborg Farver-Vestergaard Rikke Ibsen Anders L økke Source Type: research
Incidence and Outcomes of Posterior Circulation Involvement in Moyamoya Disease
CONCLUSIONS: PCA disease involvement in MMD is associated with higher rates of ischemic perioperative complications and worsened functional outcomes, likely due to reduced collateral flow. Ten-year progression of PCA disease is highly likely and should be monitored throughout follow-up; future studies will assess the impact of PCA disease progression on long-term outcomes.PMID:38567531 | DOI:10.1161/STROKEAHA.123.044693 (Source: Atherosclerosis)
Source: Atherosclerosis - April 3, 2024 Category: Cardiology Authors: Seth S Tigchelaar Allan R Wang Silvia D Vaca Yiping Li Gary K Steinberg Source Type: research
Scarring alopecia from cutaneous sarcoidosis of the scalp
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024018. doi: 10.36141/svdld.v41i1.15660.NO ABSTRACTPMID:38567553 | DOI:10.36141/svdld.v41i1.15660 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Michelle Sikora Chinemelum Obijiofor Kristen Lo Sicco Avrom Caplan Source Type: research
Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024024. doi: 10.36141/svdld.v41i1.15515.NO ABSTRACTPMID:38567554 | DOI:10.36141/svdld.v41i1.15515 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Laura C Price Vaileios Kouranos Robert Baughman Chloe Bloom Iain Stewart Oksana Shlobin Steven Nathan Konstantinos Dimopoulos Jonathan Falconer Rohit Gupta Colm McCabe Chinthaka Samaranayake Thomas Mason Bhashkhar Mukherjee Catherine Taube Ankita Sahni Al Source Type: research
Prognostic significance of antifibrotic agents in idiopathic pulmonary fibrosis after initiation of long-term oxygen therapy
CONCLUSION: In IPF patients who were introduced LTOT, treatment with antifibrotic agents was the independent factor for favorable survival. Treatment with antifibrotic agents may improve prognosis of IPF even after initiation of LTOT.PMID:38567555 | DOI:10.36141/svdld.v41i1.15264 (Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases)
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - April 3, 2024 Category: Respiratory Medicine Authors: Mayuko Ishiwari Yuta Kono Yuki Togashi Kenichi Kobayashi Ryota Kikuchi Mariko Kogami Shinji Abe Source Type: research
